MALDI Mass Spectrometry Imaging in a Primary Demyelination Model of Murine Spinal Cord.
Emily R SekeraDarpan SaraswatKevin J ZemaitisFraser J SimTroy D WoodPublished in: Journal of the American Society for Mass Spectrometry (2020)
Destruction of myelin, or demyelination, is a characteristic of traumatic spinal cord injury and pathognomonic for primary demyelinating pathologies such as multiple sclerosis (MS). The regenerative process known as remyelination, which can occur following demyelination, fails as MS progresses. Models of focal demyelination by local injection of gliotoxins have provided important biological insights into the demyelination/remyelination process. Here, injection of lysolecithin to induce spinal cord demyelination is investigated using matrix-assisted laser desorption/ionization mass spectrometry imaging. A segmentation analysis revealed changes to the lipid composition during lysolecithin-induced demyelination at the lesion site and subsequent remyelination over time. The results of this study can be utilized to identify potential myelin-repair mechanisms and in the design of therapeutic strategies to enhance myelin repair.
Keyphrases
- mass spectrometry
- spinal cord injury
- spinal cord
- multiple sclerosis
- high resolution
- liquid chromatography
- white matter
- neuropathic pain
- gas chromatography
- stem cells
- capillary electrophoresis
- high performance liquid chromatography
- mesenchymal stem cells
- ms ms
- cell therapy
- ultrasound guided
- machine learning
- bone marrow
- risk assessment
- human health